Civic Intelligence

Relapsing Polychondritis Awareness and Support Foundation

990EZ • Fiscal year 2019 • EIN 46-2458916

Apr 01, 2018 to Mar 31, 2019 • Filed on Aug 08, 2019

1202 Lexington Ave Ste 112New York, NY 10028

(906) 225-1166

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2019

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2019

Net Margin

30th percentile

-5.1%

Higher net margin than 30% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Top Officer Pay

84th percentile

$0

Higher top officer pay than 84% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Asset Growth

12th percentile

-38%

Faster asset growth than 12% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Revenue Growth

94th percentile

123%

Faster revenue growth than 94% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Assets

Down

$8,330

Down $5,052 (-38%) from 2018

Net Assets

$8,330

No earlier filing loaded for comparison.

Liabilities

-

No earlier filing loaded for comparison.

Revenue

Up

$104,785

Up $57,841 (+123%) from 2018

Expenses

Up

$110,149

Up $72,421 (+192%) from 2018

Net Income

Down

-$5,364

Down $14,580 (-158%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2018: $13,382Liabilities 2018: $02018Assets 2019: $8,330Net Assets 2019: $8,3302019Assets 2020: $107,678Liabilities 2020: $0Net Assets 2020: $107,6782020Assets 2021: $1,125,824Liabilities 2021: $0Net Assets 2021: $1,125,8242021Assets 2022: $1,026,239Liabilities 2022: $0Net Assets 2022: $1,026,2392022Assets 2023: $626,337Liabilities 2023: $2,463Net Assets 2023: $623,8742023Assets 2024: $386,620Liabilities 2024: $2,738Net Assets 2024: $383,8822024Assets 2025: $742,497Liabilities 2025: $3,336Net Assets 2025: $739,1612025

Highlighted filing

2019

Assets$8,330
Liabilities-
Net Assets$8,330

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MRevenue 2018: $46,944Expenses 2018: $37,728Net Income 2018: $9,2162018Revenue 2019: $104,785Expenses 2019: $110,149Net Income 2019: -$5,3642019Revenue 2020: $847,514Expenses 2020: $748,162Net Income 2020: $99,3522020Revenue 2021: $2,119,857Expenses 2021: $1,101,711Net Income 2021: $1,018,1462021Revenue 2022: $1,006,610Expenses 2022: $1,106,195Net Income 2022: -$99,5852022Revenue 2023: $987,715Expenses 2023: $1,390,080Net Income 2023: -$402,3652023Revenue 2024: $641,371Expenses 2024: $881,363Net Income 2024: -$239,9922024Revenue 2025: $1,342,039Expenses 2025: $986,760Net Income 2025: $355,2792025

Highlighted filing

2019

Revenue$104,785
Expenses$110,149
Net Income-$5,364
Jump To
Filing Snapshot
Filing Period
Apr 1, 2018 to Mar 31, 2019
Signed
Aug 8, 2019
Return Version
2018v3.1
Gross Receipts
$106,215
Mission and Program Overview

Mission

The rp foundation's mission is to: (a) increase awareness about relapsing polychondritis; (b) provide support (primarily through the use of the internet, social media, and patient advocacy programs) for those who are affected by relapsing polychondritis, support research to advance a cure for relapsing polychondritis; (c) promote quality care for relapsing polychondritis patients; and (d) engage in such other activities in connection therewith that the board of directors may authorize, in all cases subject to the provision of section 501(c)(3) of the internal revenu code of 1986, as amended, or the corresponding provisions of any subsequent federal tax law (the "code").

To increase awareness about relapsing polychondritis to provide support for those who are affected by relapsing polychondritis to support research to advance a cure for relapsing polychondritis to promote quality care for relapsing polychondritis patients to engage in such other activites in connection therewith that the board of directors may authorize, subject to provisions of section 501(c)(3) of the internal revenue code

Program Services

DescriptionGrantsExpenses
RPASF HAS EXPERIENCED UNPRECEDENTED GROWTH AND ACCOMPLISHED A NUMBER OF INITIATIVES, WHICH WERE CONSISTENT WITH THE FOUNDATION'S PURPOSE. RPASF INCREASED AWARENESS REGARDING RELAPSING POLYCHONDRITIS (RP) THROUGH ITS PARTICIPATION AT: -THE AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) ANNUAL MEETING IN CHICAGO; AND -AUTOIMMUNE WALKS (NEW YORK AND LOS ANGELES) ADDITIONALLY, RPASF COLLABORATED WITH MARCELLI MOTORSPORTS. AS A BRAND AMBASSADOR AND PROFESSIONAL RACE CAR DRIVER, KYLE MARCELLI, PROVIDED RP WITH PRESENCE TO AN ESTIMATED TWO MILLION VIEWERS IN 2018. THE FOUNDATION ESTABLISHED STRATEGIC COMMUNICATIONS AND PROGRAMS WITH SCIENTISTS, CLINICIANS AND THE BIOPHARM INDUSTRIES TO FACILITATE RESEARCH AND ACCELERATE DISCOVERIES THAT WILL LEAD TO A CURE FOR PATIENTS BATTLING RP. SPECIFICALLY, THE FOUNDATION: -PARTNERED WITH RACE FOR RP, AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION (AARDA), ALLEGHENY HEALTH NETWORK AUTOIMMUNE INSTITUTE, UNIVERSITY OF MICHIGAN DIVISION OF RHEUMATOLOGY, NATIONAL INSTITUTE OF HEALTH, LUPUS FOUNDATION OF AMERICA, FOUNDATION FOR THE AUTOIMMUNITY INSTITUTE, AND THE BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON, -WAS FEATURED ON THE COVER OF AARDA'S IN FOCUS NEWSLETTER WITH JANE BUCKNER -EXPANDED OUR NETWORK TO NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD); AND -FACILITATED A GIFT TO THE UNIVERSITY OF MICHIGAN DIVISION OF RHEUMATOLOGY TO SEND A COHORT OF FACULTY RESEARCHERS TO THE NIH TO FACILITATE THE COLLABORATION WITH CLINCIAL RESEARCHERS RP IS AN UNCOMMON DISEASE THAT AFFECTS APPROXIMATELY 3-5 INDIVIDUALS PER MILLION PEOPLE. RPASF'S SERVICES AND PROGRAMS ARE BENEFITTING ALL RP PATIENTS AND THEIR FAMILY AND FRIENDS.-$65,341
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
NANCY LINNDirector/CHAPT$0--
MICHAEL LINNDirector/VicPT$0--
DAVID BAMMERTPresidentPT$0--
DAVID DEROSASecretary/TrPT$0--
Filing and Contact Details

Filer

Filer Name
Relapsing Polychondritis Awareness
EIN
46-2458916
Phone
9062251166
Address
1202 LEXINGTON AVE STE 112, NEW YORK, NY 10028

Signing Officer

Name
David Bammert
Title
President
Phone
9062251166
Signed
2019-08-08
Discuss with paid preparer
Yes

Preparer

Firm
Anderson Tackman & Company Plc
Address
102 W WASHINGTON ST STE 109, MARQUETTE, MI 49855
Preparer
William C Sheltrow CPA
Phone
9062251166
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses advertising 5,160 office supplies 459 computer/it 3,002 lodging 4,585 travel 22,155 insurance 3,475 bank fees 106 meals & entertainment 919 telephone/communications 180 merchant fees 90 other costs 4,409 fees and setup 1,645 total 46,185

Form 990-ez, Part I, Line 20

Prior period adjustment 312

Form 990-ez, Part III

To increase awareness about relapsing polychondritis to provide support for those who are affected by relapsing polychondritis to support research to advance a cure for relapsing polychondritis to promote quality care for relapsing polychondritis patients to engage in such other activites in connection therewith that the board of directors may authorize, subject to provisions of section 501(c)(3) of the internal revenue code

Form 990-ez, Part III, Line 28

Rpasf has experienced unprecedented growth and accomplished a number of initiatives, which were consistent with the foundation's purpose. Rpasf increased awareness regarding relapsing polychondritis (rp) through its participation at: -the american college of rheumatology (acr) annual meeting in chicago; and -autoimmune walks (new york and los angeles) additionally, rpasf collaborated with marcelli motorsports. As a brand ambassador and professional race car driver, kyle marcelli, provided rp with presence to an estimated two million viewers in 2018. The foundation established strategic communications and programs with scientists, clinicians and the biopharm industries to facilitate research and accelerate discoveries that will lead to a cure for patients battling rp. Specifically, the foundation: -partnered with race for rp, american autoimmune related disease association (aarda), allegheny health network autoimmune institute, university of michigan division of rheumatology, national institute of health, lupus foundation of america, foundation for the autoimmunity institute, and the benaroya research institute at virginia mason, -was featured on the cover of aarda's in focus newsletter with jane buckner -expanded our network to national organization for rare disorders (nord); and -facilitated a gift to the university of michigan division of rheumatology to send a cohort of faculty researchers to the nih to facilitate the collaboration with clincial researchers rp is an uncommon disease that affects approximately 3-5 individuals per million people. Rpasf's services and programs are benefitting all rp patients and their family and friends.

Raw XML Appendix164 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0DAVID BAMMERT
IRS990EZ/BooksInCareOfDetail/PhoneNum09062251166
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01202 LEXINGTON AVE BOX 112
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010028
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt013382
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt08330
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt099437
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-5364
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt057373
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt013382
IRS990EZ/Form990TotalAssetsGrp/EOYAmt08330
IRS990EZ/FundraisingGrossIncomeAmt06777
IRS990EZ/GrossReceiptsAmt0106215
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt01
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt013382
IRS990EZ/NetAssetsOrFundBalancesEOYAmt08330
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt013382
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt08330
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt06.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt16.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt26.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt36.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0NANCY LINN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1MICHAEL LINN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2DAVID BAMMERT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DAVID DEROSA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0DIRECTOR/CHA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1DIRECTOR/VIC
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SECRETARY/TR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherChangesInNetAssetsAmt0312
IRS990EZ/OtherExpensesTotalAmt046185
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0TO INCREASE AWARENESS ABOUT RELAPSING POLYCHONDRITIS TO PROVIDE SUPPORT FOR THOSE WHO ARE AFFECTED BY RELAPSING POLYCHONDRITIS TO SUPPORT RESEARCH TO ADVANCE A CURE FOR RELAPSING POLYCHONDRITIS TO PROMOTE QUALITY CARE FOR RELAPSING POLYCHONDRITIS PATIENTS TO ENGAGE IN SUCH OTHER ACTIVITES IN CONNECTION THEREWITH THAT THE BOARD OF DIRECTORS MAY AUTHORIZE, SUBJECT TO PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE
IRS990EZ/PrintingPublicationsPostageAmt06591
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0RPASF HAS EXPERIENCED UNPRECEDENTED GROWTH AND ACCOMPLISHED A NUMBER OF INITIATIVES, WHICH WERE CONSISTENT WITH THE FOUNDATION'S PURPOSE. RPASF INCREASED AWARENESS REGARDING RELAPSING POLYCHONDRITIS (RP) THROUGH ITS PARTICIPATION AT: -THE AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) ANNUAL MEETING IN CHICAGO; AND -AUTOIMMUNE WALKS (NEW YORK AND LOS ANGELES) ADDITIONALLY, RPASF COLLABORATED WITH MARCELLI MOTORSPORTS. AS A BRAND AMBASSADOR AND PROFESSIONAL RACE CAR DRIVER, KYLE MARCELLI, PROVIDED RP WITH PRESENCE TO AN ESTIMATED TWO MILLION VIEWERS IN 2018. THE FOUNDATION ESTABLISHED STRATEGIC COMMUNICATIONS AND PROGRAMS WITH SCIENTISTS, CLINICIANS AND THE BIOPHARM INDUSTRIES TO FACILITATE RESEARCH AND ACCELERATE DISCOVERIES THAT WILL LEAD TO A CURE FOR PATIENTS BATTLING RP. SPECIFICALLY, THE FOUNDATION: -PARTNERED WITH RACE FOR RP, AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION (AARDA), ALLEGHENY HEALTH NETWORK AUTOIMMUNE INSTITUTE, UNIVERSITY OF MICHIGAN DIVISION OF RHEUMATOLOGY, NATIONAL INSTITUTE OF HEALTH, LUPUS FOUNDATION OF AMERICA, FOUNDATION FOR THE AUTOIMMUNITY INSTITUTE, AND THE BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON, -WAS FEATURED ON THE COVER OF AARDA'S IN FOCUS NEWSLETTER WITH JANE BUCKNER -EXPANDED OUR NETWORK TO NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD); AND -FACILITATED A GIFT TO THE UNIVERSITY OF MICHIGAN DIVISION OF RHEUMATOLOGY TO SEND A COHORT OF FACULTY RESEARCHERS TO THE NIH TO FACILITATE THE COLLABORATION WITH CLINCIAL RESEARCHERS RP IS AN UNCOMMON DISEASE THAT AFFECTS APPROXIMATELY 3-5 INDIVIDUALS PER MILLION PEOPLE. RPASF'S SERVICES AND PROGRAMS ARE BENEFITTING ALL RP PATIENTS AND THEIR FAMILY AND FRIENDS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt065341
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt01430
IRS990EZ/SpecialEventsNetIncomeLossAmt05347
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0110149
IRS990EZ/TotalProgramServiceExpensesAmt065341
IRS990EZ/TotalRevenueAmt0104785
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.POLYCHONDRITIS.ORG
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/CurrentTaxYearMinus2YearsAmt02000
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt02000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt099437
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt041516
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt067300
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt019255
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt09096
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0236604
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt01
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt01
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt05248
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt017420
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt07139
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0749
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt030556
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt01
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt01
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearAmt04347
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt04347
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.89190
IRS990ScheduleA/PublicSupportPY509Pct00.94550
IRS990ScheduleA/PublicSupportTotal509Amt0242160
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearMinus1YearAmt011000
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearMinus2YearsAmt014000
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt025000
IRS990ScheduleA/SubstantialContributorsAmtGrp/CurrentTaxYearMinus1YearAmt011000
IRS990ScheduleA/SubstantialContributorsAmtGrp/CurrentTaxYearMinus2YearsAmt012000
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt023000
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt099437
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt046764
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt084720
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt026394
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt09845
IRS990ScheduleA/Total509Grp/TotalAmt0267160
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0103785
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt046764
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt084720
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt026394
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt09845
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0271508
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES ADVERTISING 5,160 OFFICE SUPPLIES 459 COMPUTER/IT 3,002 LODGING 4,585 TRAVEL 22,155 INSURANCE 3,475 BANK FEES 106 MEALS & ENTERTAINMENT 919 TELEPHONE/COMMUNICATIONS 180 MERCHANT FEES 90 OTHER COSTS 4,409 FEES AND SETUP 1,645 TOTAL 46,185
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1PRIOR PERIOD ADJUSTMENT 312
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2TO INCREASE AWARENESS ABOUT RELAPSING POLYCHONDRITIS TO PROVIDE SUPPORT FOR THOSE WHO ARE AFFECTED BY RELAPSING POLYCHONDRITIS TO SUPPORT RESEARCH TO ADVANCE A CURE FOR RELAPSING POLYCHONDRITIS TO PROMOTE QUALITY CARE FOR RELAPSING POLYCHONDRITIS PATIENTS TO ENGAGE IN SUCH OTHER ACTIVITES IN CONNECTION THEREWITH THAT THE BOARD OF DIRECTORS MAY AUTHORIZE, SUBJECT TO PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3RPASF HAS EXPERIENCED UNPRECEDENTED GROWTH AND ACCOMPLISHED A NUMBER OF INITIATIVES, WHICH WERE CONSISTENT WITH THE FOUNDATION'S PURPOSE. RPASF INCREASED AWARENESS REGARDING RELAPSING POLYCHONDRITIS (RP) THROUGH ITS PARTICIPATION AT: -THE AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) ANNUAL MEETING IN CHICAGO; AND -AUTOIMMUNE WALKS (NEW YORK AND LOS ANGELES) ADDITIONALLY, RPASF COLLABORATED WITH MARCELLI MOTORSPORTS. AS A BRAND AMBASSADOR AND PROFESSIONAL RACE CAR DRIVER, KYLE MARCELLI, PROVIDED RP WITH PRESENCE TO AN ESTIMATED TWO MILLION VIEWERS IN 2018. THE FOUNDATION ESTABLISHED STRATEGIC COMMUNICATIONS AND PROGRAMS WITH SCIENTISTS, CLINICIANS AND THE BIOPHARM INDUSTRIES TO FACILITATE RESEARCH AND ACCELERATE DISCOVERIES THAT WILL LEAD TO A CURE FOR PATIENTS BATTLING RP. SPECIFICALLY, THE FOUNDATION: -PARTNERED WITH RACE FOR RP, AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION (AARDA), ALLEGHENY HEALTH NETWORK AUTOIMMUNE INSTITUTE, UNIVERSITY OF MICHIGAN DIVISION OF RHEUMATOLOGY, NATIONAL INSTITUTE OF HEALTH, LUPUS FOUNDATION OF AMERICA, FOUNDATION FOR THE AUTOIMMUNITY INSTITUTE, AND THE BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON, -WAS FEATURED ON THE COVER OF AARDA'S IN FOCUS NEWSLETTER WITH JANE BUCKNER -EXPANDED OUR NETWORK TO NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD); AND -FACILITATED A GIFT TO THE UNIVERSITY OF MICHIGAN DIVISION OF RHEUMATOLOGY TO SEND A COHORT OF FACULTY RESEARCHERS TO THE NIH TO FACILITATE THE COLLABORATION WITH CLINCIAL RESEARCHERS RP IS AN UNCOMMON DISEASE THAT AFFECTS APPROXIMATELY 3-5 INDIVIDUALS PER MILLION PEOPLE. RPASF'S SERVICES AND PROGRAMS ARE BENEFITTING ALL RP PATIENTS AND THEIR FAMILY AND FRIENDS.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 20
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02019-02-21 02:37:17Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0DAVID BAMMERT
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum09062251166
ReturnHeader/BusinessOfficerGrp/SignatureDt02019-08-08
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0RELAPSING POLYCHONDRITIS AWARENESS
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0AND SUPPORT FOUNDATION INC
ReturnHeader/Filer/BusinessNameControlTxt0RELA
ReturnHeader/Filer/EIN0462458916
ReturnHeader/Filer/PhoneNum09062251166
ReturnHeader/Filer/USAddress/AddressLine1Txt01202 LEXINGTON AVE STE 112
ReturnHeader/Filer/USAddress/CityNm0NEW YORK
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd010028
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId019D33CB9A5303C4E200284C543BBABF1E1BEE30C
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId019D33CB9A5303C4E200284C543BBABF1E1BEE30C
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt024.213.4.170
ReturnHeader/FilingSecurityInformation/IPDt02019-08-12
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CD
ReturnHeader/FilingSecurityInformation/IPTm013:00:54
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0381977929
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0ANDERSON TACKMAN & COMPANY PLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0102 W WASHINGTON ST STE 109
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0MARQUETTE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0MI
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd049855
ReturnHeader/PreparerPersonGrp/PhoneNum09062251166
ReturnHeader/PreparerPersonGrp/PreparationDt02019-08-12
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0WILLIAM C SHELTROW CPA
ReturnHeader/ReturnTs02019-08-12T13:00:54-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02018-04-01
ReturnHeader/TaxPeriodEndDt02019-03-31
ReturnHeader/TaxYr02018

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings